Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04996004
Title A Trial of TTI-621 in Combination With Doxorubicin in Patients With Leiomyosarcoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Trillium Therapeutics Inc.
Indications

dedifferentiated liposarcoma

myxofibrosarcoma

angiosarcoma

leiomyosarcoma

epithelioid sarcoma

Therapies

Doxorubicin + TTI-621

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.